rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
19 Suppl
|
pubmed:dateCreated |
1999-1-8
|
pubmed:abstractText |
Idiopathic hypertrophic obstructive cardiomyopathy (HOCM) is characterized by regional myocardial hypertrophy. In our previous study, we demonstrated that mRNA levels for insulin-like growth factor-I (IGF-I) and transforming growth factor-beta 1 (TGF-beta 1) were elevated in HOCM tissue. In this study, we investigated IGF-I and TGF-beta 1 protein levels and their respective receptor levels and localization.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0009-7322
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
10
|
pubmed:volume |
98
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
II144-9; discussion II149-50
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9852896-Angina Pectoris,
pubmed-meshheading:9852896-Binding Sites,
pubmed-meshheading:9852896-Cardiomyopathy, Hypertrophic,
pubmed-meshheading:9852896-Humans,
pubmed-meshheading:9852896-Hypertrophy, Left Ventricular,
pubmed-meshheading:9852896-Immunohistochemistry,
pubmed-meshheading:9852896-Insulin-Like Growth Factor I,
pubmed-meshheading:9852896-Myocardial Ischemia,
pubmed-meshheading:9852896-Myocardium,
pubmed-meshheading:9852896-Receptors, Somatomedin,
pubmed-meshheading:9852896-Receptors, Transforming Growth Factor beta,
pubmed-meshheading:9852896-Tissue Distribution,
pubmed-meshheading:9852896-Transforming Growth Factor beta
|
pubmed:year |
1998
|
pubmed:articleTitle |
Elevated insulin-like growth factor-I and transforming growth factor-beta 1 and their receptors in patients with idiopathic hypertrophic obstructive cardiomyopathy. A possible mechanism.
|
pubmed:affiliation |
Centre for Cardiovascular Research, Toronto Hospital, University of Toronto, Ontario, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|